Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pouquet

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
International Journal of Environmental Research and Public Health|February 25, 2022
A Cross-Sectional Study of Exposure Factors Associated with Seropositivity for SARS-CoV-2 Antibodies during the Second Epidemic Wave among a Sample of the University of Corsica (France)Dorine Decarreaux, Julie Sevila, Shirley Masse, et al.
Anticancer Research|July 15, 2009
Chemotherapy response evaluation in metastatic colorectal cancer with FDG PET/CT and CT scansJ Monteil, N Mahmoudi, S Leobon, et al.
Cancer Chemotherapy and Pharmacology|September 25, 2019
Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignanciesLeonard J Appleman, Jan H Beumer, Yixing Jiang, et al.
Pathogens (Basel, Switzerland)|August 6, 2021
Nationwide Seroprevalence of SARS-CoV-2 IgG Antibodies among Four Groups of Primary Health-Care Workers and Their Household Contacts 6 Months after the Initiation of the COVID-19 Vaccination Campaign in France: SeroPRIM Study ProtocolMarie Pouquet, Dorine Decarreaux, Pol Prévot-Monsacré, et al.
Viruses|May 28, 2022
Seroprevalence of SARS-CoV-2 IgG Antibodies and Factors Associated with SARS-CoV-2 IgG Neutralizing Activity among Primary Health Care Workers 6 Months after Vaccination Rollout in FranceDorine Decarreaux, Marie Pouquet, Cecile Souty, et al.
Scientific Reports|March 5, 2024
SARS-CoV-2 infection prevalence and associated factors among primary healthcare workers in France after the third COVID-19 waveMarie Pouquet, Dorine Decarreaux, Laura Di Domenico, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2016
A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Myeloid LeukemiaIvana Gojo, Jan H Beumer, Keith W Pratz, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
International Journal of Environmental Research and Public Health|February 25, 2022
A Cross-Sectional Study of Exposure Factors Associated with Seropositivity for SARS-CoV-2 Antibodies during the Second Epidemic Wave among a Sample of the University of Corsica (France)Dorine Decarreaux, Julie Sevila, Shirley Masse, et al.
Anticancer Research|July 15, 2009
Chemotherapy response evaluation in metastatic colorectal cancer with FDG PET/CT and CT scansJ Monteil, N Mahmoudi, S Leobon, et al.
Cancer Chemotherapy and Pharmacology|September 25, 2019
Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignanciesLeonard J Appleman, Jan H Beumer, Yixing Jiang, et al.
Pathogens (Basel, Switzerland)|August 6, 2021
Nationwide Seroprevalence of SARS-CoV-2 IgG Antibodies among Four Groups of Primary Health-Care Workers and Their Household Contacts 6 Months after the Initiation of the COVID-19 Vaccination Campaign in France: SeroPRIM Study ProtocolMarie Pouquet, Dorine Decarreaux, Pol Prévot-Monsacré, et al.
Viruses|May 28, 2022
Seroprevalence of SARS-CoV-2 IgG Antibodies and Factors Associated with SARS-CoV-2 IgG Neutralizing Activity among Primary Health Care Workers 6 Months after Vaccination Rollout in FranceDorine Decarreaux, Marie Pouquet, Cecile Souty, et al.
Scientific Reports|March 5, 2024
SARS-CoV-2 infection prevalence and associated factors among primary healthcare workers in France after the third COVID-19 waveMarie Pouquet, Dorine Decarreaux, Laura Di Domenico, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2016
A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Myeloid LeukemiaIvana Gojo, Jan H Beumer, Keith W Pratz, et al.
Pageof 8